ArticleOncology letters2024

TTC22 as a potential prognostic marker and therapeutic target in pancreatic cancer: Insights into immune infiltration and epithelial‑mesenchymal transition.

Yuntao Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.